S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
OTCMKTS:PTCHF

PureTech Health (PTCHF) Stock Price, News & Analysis

$2.78
0.00 (0.00%)
(As of 04/12/2024 ET)
Today's Range
$2.78
$2.78
50-Day Range
$2.30
$2.85
52-Week Range
$1.69
$3.10
Volume
N/A
Average Volume
36,954 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PTCHF stock logo

About PureTech Health Stock (OTCMKTS:PTCHF)

PureTech Health plc, a clinical stage biotherapeutics company, engages in the discovery, development, and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, currently under Phase 3 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, to inhibit the activity of galectin-9 for treating solid tumors and hematological malignancies. It is also developing LYT-300, an oral allopregnanolone, currently completed Phase 1 stage, to treat depression, anxiety, and related indications; and LYT-310, an oral cannabidiol, currently under preclinical stage, to treat epilepsies and other neurological indications. In addition, the company is developing LYT-503/IMB-150, a non-opioid inflammation targeted disease immunomodulation for the potential treatment of interstitial cystitis, or bladder pain syndrome; and Glyph technology platform, a lymphatic-targeting chemistry platform, which leverages the body's natural lipid absorption and transports the process to orally administer drugs via the lymphatic system. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

PTCHF Stock Price History

PTCHF Stock News Headlines

PureTech Health: Repeat What Works
Gold Hits New All-Time Highs
Due to both domestic and global issues, the trajectory of this precious metal could skyrocket in the coming months… Which is why billionaires and Central Banks alike are scooping up gold at record rates!
PureTech Health plc (PTCHF)
PureTech Year End Update and Outlook for 2024
PureTech Health PLC PRTC
Gold Hits New All-Time Highs
Due to both domestic and global issues, the trajectory of this precious metal could skyrocket in the coming months… Which is why billionaires and Central Banks alike are scooping up gold at record rates!
Results of PureTech's Annual General Meeting
Full Year 2023 PureTech Health PLC Earnings Call
PRTC.L - | Stock Price & Latest News | Reuters
PureTech Health plc (PRTC.L)
See More Headlines
Receive PTCHF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:PTCHF
Fax
N/A
Employees
111
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Ms. Daphne Zohar (Age 53)
    Founder, CEO & Executive Director
    Comp: $1.01M
  • Dr. Bharatt M. Chowrira J.D. (Age 59)
    Ph.D., President & Executive Director
    Comp: $800.55k
  • Dr. Robert S. Langer Jr. (Age 75)
    Ph.D., Co-Founder & Non-Executive Director
    Comp: $145k
  • Dr. David R. Elmaleh Ph.D. (Age 76)
    Co-Founder & Senior Advisor
  • Ms. Allison Mead Talbot
    Head of Communications & Investor Relations
  • Mr. Spencer Ball
    Senior Vice President of Human Resources
  • Dr. Eric Elenko Ph.D. (Age 51)
    Chief Innovation & Strategy Officer
  • Ms. Aleksandra Filipovic M.D.
    Ph.D., Head of Oncology
  • Ms. Cheryl Murphy Ph.D.
    Head of Grants Management & Strategy
  • Ms. Anita Terpstra J.D.
    Ph.D., Senior VP & Head of Intellectual Property

PTCHF Stock Analysis - Frequently Asked Questions

How have PTCHF shares performed in 2024?

PureTech Health's stock was trading at $2.38 on January 1st, 2024. Since then, PTCHF shares have increased by 16.8% and is now trading at $2.78.
View the best growth stocks for 2024 here
.

Are investors shorting PureTech Health?

PureTech Health saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 68,400 shares, an increase of 38.7% from the March 15th total of 49,300 shares. Based on an average daily trading volume, of 56,200 shares, the days-to-cover ratio is presently 1.2 days.
View PureTech Health's Short Interest
.

How do I buy shares of PureTech Health?

Shares of PTCHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PTCHF) was last updated on 4/13/2024 by MarketBeat.com Staff

From Our Partners